To provide an explanation of some clinical features observed within rare xe
roderma pigmentosum (XP) patients and to further define the role of XPB, XP
D, and cdk7, the three enzymatic subunits of TFIIH, in the transcription re
action, we have examined two defined enzymatic steps: phosphodiester bond f
ormation and promoter escape, me provide evidence that the XPB helicase pla
ys a dominant role in initiation, whereas the XPD helicase plays a minor co
ntributing role in this step. The cyclin-activating kinase subcomplex of TF
IIH improves the efficiency of initiation, but this involves only the struc
tural contributions of cyclin-activating kinase rather than enzymatic activ
ity. We demonstrate that XPB patient-derived mutants in TFIIH suffer from d
efects in initiation. Moreover, mutant analysis shows that in addition to i
ts crucial role in initiation, the XPB helicase plays a critical enzymatic
role in the promoter escape, whereas XPD plays an important structural role
in the promoter escape process. Finally, using patient-derived mutations i
n TFIIH, we demonstrate deficiencies in promoter escape for both mutants of
the class that suffer from combined xeroderma pigmentosum/Cockayne's syndr
ome.